BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 14499877)

  • 1. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
    Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
    Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
    Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.
    Knapp AC; Huang J; Starling G; Kiener PA
    Atherosclerosis; 2000 Sep; 152(1):217-27. PubMed ID: 10996358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
    Alfon J; Guasch JF; Berrozpe M; Badimon L
    Atherosclerosis; 1999 Aug; 145(2):325-31. PubMed ID: 10488960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W; Dulak J; Frick M; Alber HF; Schwarzacher SP; Ares MP; Nilsson J; Pachinger O; Weidinger F
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):58-63. PubMed ID: 12524225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Martínez-González J; Alfón J; Berrozpe M; Badimon L
    Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
    Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
    Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
    Parker RA; Huang Q; Tesfamariam B
    Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.
    Tesfamariam B; Frohlich BH; Gregg RE
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):95-101. PubMed ID: 10413074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins regulate alpha2beta1-integrin expression and collagen I-dependent functions in human vascular smooth muscle cells.
    Graf K; Kappert K; Stawowy P; Bokemeyer J; Blaschke F; Schmidt G; Kintscher U; Goetze S; Fleck E
    J Cardiovasc Pharmacol; 2003 Jan; 41(1):89-96. PubMed ID: 12500026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic statins induce apoptosis of human vascular smooth muscle cells.
    Guijarro C; Blanco-Colio LM; Massy ZA; O'Donnell MP; Kasiske BL; Keane WF; Egido J
    Kidney Int Suppl; 1999 Jul; 71():S88-91. PubMed ID: 10412746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
    Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages.
    Huang KC; Chen CW; Chen JC; Lin WW
    J Biomed Sci; 2003; 10(4):396-405. PubMed ID: 12824699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.